The University of Chicago Header Logo

Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma.

Bevacizumab Alone and in Combination With Irinotecan in Recurrent Glioblastoma. J Clin Oncol. 2023 Nov 10; 41(32):4945-4952.

View in: PubMed